Tirzepatide requires a prescription, and there are several ways to get one: through your primary care doctor, an endocrinologist or obesity medicine specialist, or a telehealth platform. The route that makes the most sense for you depends on whether you need it for type 2 diabetes or weight loss, what your insurance covers, and how much you’re willing to pay out of pocket.
What Tirzepatide Is Approved For
Tirzepatide is sold under two brand names, each approved for a different condition. Mounjaro is approved for improving blood sugar control in adults and children 10 and older with type 2 diabetes. Zepbound is approved for chronic weight management in adults with obesity or overweight who also have a weight-related health condition.
The distinction matters because your diagnosis determines which version gets prescribed, which insurance pathway applies, and what eligibility criteria you need to meet.
Who Qualifies for a Prescription
For type 2 diabetes (Mounjaro), the main requirement is a confirmed diagnosis. Your doctor will typically check your A1c, blood sugar, and kidney and liver function before prescribing.
For weight management (Zepbound), the FDA-approved criteria are straightforward: you need a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease. These BMI thresholds are measured before starting any GLP-1 medication, so if you’ve already lost weight on a similar drug, your baseline BMI still counts.
Insurance companies layer additional requirements on top of the FDA label. Cigna, for example, requires that you’ve tried behavioral modification and dietary changes for at least three months before they’ll approve Zepbound. They also require that you continue diet and lifestyle changes while on the medication. Other insurers have similar step-therapy policies, and some don’t cover weight loss medications at all.
Getting a Prescription Through Your Doctor
The most straightforward path is asking your primary care doctor or a specialist. Before writing a prescription, most providers will take baseline measurements (height, weight, BMI) and may order blood work depending on your situation: blood pressure, cholesterol, A1c, blood sugar, kidney function, liver function, thyroid function, and a complete blood count. Not every patient needs every test, but expect at least a few of these, especially if you haven’t had recent lab work.
If your doctor isn’t comfortable prescribing tirzepatide or doesn’t treat obesity, ask for a referral to an endocrinologist or a board-certified obesity medicine physician. These specialists are more familiar with the medication, the dosing schedule, and how to navigate insurance approvals.
Using Telehealth Platforms
Dozens of telehealth companies now prescribe tirzepatide online. The typical process takes under an hour: you fill out a medical questionnaire covering your weight, health conditions, and medications. A licensed provider reviews your information, and if you’re approved, the prescription is either sent to your local pharmacy or filled by a partner pharmacy that ships directly to your door.
Prices vary widely. On the lower end, some platforms advertise compounded tirzepatide starting around $175 to $249 per month. Mid-range options run $299 to $399 per month. At higher doses, costs can reach $499 or more monthly. Many platforms offer discounts for multi-month commitments, with three-month and six-month plans reducing the per-month cost by $50 to $100.
Be selective about which platform you use. A legitimate telehealth provider will have you evaluated by a licensed prescriber in your state, ask detailed medical questions, and ship from a licensed pharmacy with proper cold-chain packaging. More on spotting red flags below.
Brand-Name Costs and Savings Programs
Without insurance coverage, brand-name Zepbound is expensive. Eli Lilly, the manufacturer, has introduced several savings options to bring costs down. If you have commercial insurance that doesn’t cover Zepbound, the company offers the single-dose pen for as low as $499 per month. The multi-dose KwikPen format is cheaper: $299 per month for the starting 2.5 mg dose, $399 for 5 mg, $449 for 7.5 mg, and $449 for the 10 mg, 12.5 mg, or 15 mg doses.
For patients paying entirely out of pocket (no insurance at all), the self-pay KwikPen prices are $299 at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg, and $699 at the higher doses. These prices are available directly through Lilly’s savings program, which you can access at zepbound.lilly.com. You’ll still need a valid prescription.
Navigating Insurance and Prior Authorization
If your insurance does cover tirzepatide, expect a prior authorization process. Your prescriber submits documentation proving you meet the criteria, and the insurer reviews it before approving or denying coverage. This can take anywhere from a few days to a few weeks.
Common requirements across major insurers include proof that your BMI meets the threshold, documentation of at least one weight-related condition (for the 27-29.9 BMI range), evidence that you’ve attempted diet and behavioral changes for at least three months, and confirmation that you’re not combining tirzepatide with another GLP-1 medication. Your doctor’s office handles most of this paperwork, but you can speed things up by having your recent lab results and weight history readily available.
If you’re denied, ask your doctor about an appeal. Many initial denials are overturned when additional documentation is submitted. Some prescribers’ offices have staff dedicated to navigating these appeals.
What About Compounded Tirzepatide?
Compounded tirzepatide is a version made by specialty pharmacies rather than by Eli Lilly. It became widely available when tirzepatide was on the FDA’s drug shortage list, which allowed compounding pharmacies to produce it legally. That situation has changed. Tirzepatide no longer appears on the FDA’s drug shortage list or on the approved bulk drug substances list, which significantly restricts when and how pharmacies can legally compound it.
Under current rules, a compounding pharmacy operating under section 503A of federal law can still make a compounded version for an individual patient with a prescription, but it cannot be “essentially a copy” of the commercially available product unless the prescriber documents that a specific change in the compounded version produces a meaningful difference for that particular patient. Outsourcing facilities (503B pharmacies) face even tighter restrictions and generally cannot compound tirzepatide now that the shortage has resolved.
This means the legal landscape for compounded tirzepatide is shifting and uncertain. Many telehealth platforms still offer it, but the regulatory ground beneath them is narrowing. If you go this route, understand that compounded drugs do not go through the FDA’s approval process for safety and effectiveness, and the quality depends entirely on the pharmacy producing them.
How to Spot Unsafe Sources
The FDA has flagged fraudulent compounded tirzepatide products circulating in the U.S. Some carry the name of pharmacies that don’t exist. Others use the name of a real licensed pharmacy that didn’t actually make the product. The agency has also warned against products labeled “for research purposes” or “not for human consumption” that are sold directly to people with dosing instructions.
Red flags to watch for:
- Spelling errors or incorrect addresses on the product label
- No prescription required before purchase
- No licensed prescriber evaluating your medical history
- Product arrives warm or without proper refrigeration, which can degrade the medication
- Labels saying “research use only” or similar disclaimers
- Prices that seem too good to be true compared to the market range
If you receive a product and something looks off, contact the pharmacy listed on the label to verify they actually produced it. Only purchase from state-licensed pharmacies, and only with a prescription from a licensed provider.
What the Process Looks Like Start to Finish
Whether you go through your doctor or a telehealth platform, the timeline is similar. You’ll have an initial evaluation, which may include blood work. If approved, your first prescription will be for the lowest dose (2.5 mg weekly), which you’ll take for four weeks before moving up. The dose increases gradually over several months, with most patients reaching their maintenance dose after 20 weeks or longer. Each step up gives your body time to adjust and helps minimize side effects like nausea.
Tirzepatide is a once-weekly injection you give yourself at home using a pre-filled pen. You choose a day of the week and inject into your abdomen, thigh, or upper arm. The needle is small, and most people describe it as a brief pinch. Your prescriber or the telehealth platform will schedule check-ins to monitor your progress and adjust your dose.